Primary and secondary outcome measures
PCOS
HYPERANDROGENISM, INSULIN RESISTANCE, PREGNANCY COMPLICATIONS
s-PROK1 was analysed using ELISA at gestational week 19 and related to pregnancy complications, fasting insulin levels, homoeostatic model assessment for insulin resistance (HOMA-IR), testosterone, or androstenedione levels, metformin use, PCOS phenotype and hyperandrogenism.